MR-201

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMR-201
Drug Alias Namerepurposed NMDA antagonist (Shinkei Therpaeutics)MR-201
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsMood Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSHINKEI Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSHINKEI Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMood Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A